ApoB: The Cardiovascular Marker Worth Asking For
ApoB counts the actual number of atherogenic particles in your blood. When LDL cholesterol and particle count disagree, ApoB is usually the one telling the truth.
Board-Certified Nurse Practitioner, Trained in Functional/Integrative Medicine and Bioidentical Hormone Balancing
- Also known as
- Apolipoprotein B, ApoB-100
- Measured in
- mg/dL
- Typical lab range
- Under 130 mg/dL
- Often-targeted optimal
- Often targeted below 80 mg/dL, and lower with established risk
What is ApoB?
Apolipoprotein B is a structural protein found on every atherogenic lipoprotein — LDL, VLDL, IDL, remnants, and lipoprotein(a). Each of those particles carries exactly one ApoB molecule, so measuring ApoB is effectively counting the particles capable of entering the artery wall.
A standard lipid panel reports how much cholesterol those particles are carrying. ApoB reports how many of them there are. Because atherosclerosis is driven by particle entry rather than cholesterol mass, the count is the more direct measure.
Why does it matter?
People with the same LDL cholesterol can carry very different particle numbers. Someone with insulin resistance often has many small, cholesterol-poor LDL particles: a reassuring LDL-C with a high ApoB. That discordance is common, and it is exactly the group whose risk a standard panel underestimates.
Risk tracks the number of particles that can get into the artery wall — not the cholesterol they happen to be carrying.
What does ApoB tell us?
- The total burden of atherogenic particles, in one number
- Whether LDL-C is over- or under-representing true risk
- How well a lifestyle change or therapy is actually working, on repeat testing
- Combined with lipoprotein(a), a much fuller lifetime risk picture
Why might it be missed on routine bloodwork?
Most screening guidelines and insurance pathways still center on total cholesterol, LDL-C, HDL-C, and triglycerides. ApoB is inexpensive and standardized, but it is not part of the default panel, so it is typically added only when specifically requested or when risk is already recognized.
What can cause ApoB to be high?
- Genetic conditions such as familial hypercholesterolemia
- Insulin resistance and metabolic syndrome, which increase small dense LDL particles
- Diets high in saturated fat in susceptible individuals
- Hypothyroidism, which reduces LDL receptor clearance
- Kidney disease, particularly nephrotic-range protein loss
- Excess alcohol and high triglyceride states
What can cause ApoB to be low?
A low ApoB is generally favorable from a cardiovascular standpoint and is expected with lipid-lowering therapy or a genetically low-particle phenotype. Very low values can occasionally accompany malnutrition, malabsorption, hyperthyroidism, liver disease, or rare inherited disorders of lipoprotein production, and should be interpreted alongside the rest of the panel.
Questions to discuss with your healthcare provider
- Can we measure ApoB rather than relying on calculated LDL-C alone?
- Is my ApoB discordant with my LDL cholesterol, and what does that imply?
- Given my family history, what ApoB target makes sense for me?
- Should lipoprotein(a) be measured once alongside it?
- How soon should we recheck after a dietary or medication change?
Frequently asked questions
What is a good ApoB level?
Targets are individualized by overall risk. Many prevention-focused clinicians aim below roughly 80 mg/dL for average-risk adults and considerably lower when cardiovascular disease, diabetes, or elevated lipoprotein(a) is present. Laboratory ranges are broader because they describe the population rather than an optimal target.
Do I need to fast for an ApoB test?
ApoB is relatively stable and does not strictly require fasting, though many panels are drawn fasting so that glucose, insulin, and triglycerides on the same draw remain interpretable.
Is ApoB better than LDL cholesterol?
ApoB is generally the more direct measure of atherogenic particle burden and tends to predict risk at least as well as, and often better than, LDL-C — particularly in people with insulin resistance or high triglycerides.
Want to see your own data?
ApoB is one of the advanced cardiovascular markers included in ClearSignal's Comprehensive Cardiometabolic Panel. Your results are personally reviewed and translated into a written wellness plan.
Comprehensive Cardiometabolic Panel
79 biomarkers · $329
A full-spectrum cardiometabolic and inflammatory assessment — insulin, lipids, ApoB, inflammation, and the drivers behind fatigue, brain fog, and stubborn weight.
Keep reading
Biomarker guide
Lipoprotein(a)
Lp(a) is largely genetic, stable across your lifetime, and an independent driver of cardiovascular and aortic valve risk. It needs to be measured once — and most people never have been.
Biomarker guide
hs-CRP
High-sensitivity C-reactive protein detects the low-grade, symptomless inflammation associated with cardiovascular disease, insulin resistance, and accelerated aging.
Biomarker guide
Fasting Insulin
Fasting insulin can be elevated for a decade before glucose or A1C ever move. It is one of the earliest, most actionable signals in bloodwork — and one of the most commonly skipped.
Article
Blood Tests That Matter for Longevity
Longevity medicine tracks a small set of markers that predict decades of trajectory rather than confirming today's diagnosis. Here is what those markers are and why.
Article
What Blood Tests Should I Get?
A practical framework for building a blood panel that answers real questions — what a standard physical covers, what it leaves out, and which additions change decisions.
About the author
Erica Finnan, MSN, APRN-C
Board-Certified Nurse Practitioner, Trained in Functional/Integrative Medicine and Bioidentical Hormone Balancing
Founder, ClearSignal Health
Erica Finnan is a board-certified nurse practitioner trained in functional and integrative medicine and bioidentical hormone balancing. She personally reviews every ClearSignal lab report.
Read full author profileReferences
Medical Disclaimer
The content on this blog is provided for educational and informational purposes only. It is not intended to be, and should not be taken as, medical advice, diagnosis, or treatment.
Reading this content does not create a patient-provider relationship between you and ClearSignal Health, Erica Finnan, or any clinician affiliated with ClearSignal. Nothing here is a substitute for individualized care from a licensed healthcare professional who knows your health history.
ClearSignal Health's specialist-led lab review service is a separate, dedicated offering — distinct from this blog — designed to give you an in-depth, personalized interpretation of your own results. If you have specific questions about your health, your labs, or a condition mentioned in this article, please consult your own healthcare provider or order a review through ClearSignal.
Always seek the guidance of a qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you've read here.